8: Undefined index: alttoxdisclaimer
"The U.S. Food and Drug Administration today [June 9, 2010] released draft guidance to provide regulated industries with greater certainty about the use of nanotechnology."
FDA Press Release: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm258377.htm
Draft Guidance: "Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology" available at:http://www.fda.gov/RegulatoryInformation/Guidances/ucm257698.htm
Comments on the FDA draft document can be submitted within 60 days of its publication in the Federal Register.
Release of the FDA guidance document was coordinated to occur with a Memorandum issued by the Office of Science and Technology Policy, Office of Management and Budget, and the United States Trade Representative, “Policy Principles for the U.S. Decision-Making Concerning Regulation and Oversight of Applications of Nanotechnology and Nanomaterials,” available at: http://www.whitehouse.gov/sites/default/files/omb/inforeg/for-agencies/nanotechnology-regulation-and-oversight-principles.pdf